Rocket Lab USA, Inc. Q2 2026 Earnings Call Summary
Rocket Lab USA reported Q2 2026 revenue up 62% year over year to $2.36 billion backlog, with Space Systems contracts now 60% of backlog. Management discussed the planned Iridium acquisition to support end-to-end space applications, Neutron launch cadence targets, and margin impacts from a tariff refund and Neutron inventory reserve. Iridium is expected to close mid-2027.
How this was made
The 30-second read
Why it matters
Key trading takeaways are the backlog mix shift toward Space Systems, Neutron ASP discipline, the Q4 2026 delivery target with a narrowing end-of-year window, and guidance that spending shifts from R&D to flight hardware inventory in Q3. Management also sets expectations for margin normalization after Mynaric-related supply chain issues and a free cash flow reset after Iridium closes mid-2027.
Market read
The call provides multiple concrete management disclosures that can drive near-term positioning: backlog growth and mix, Neutron ASP range, Neutron delivery timing, and a mid-2027 FCF reset narrative tied to Iridium closing.
What to watch
Gross margin was helped by a nonrecurring tariff refund and pressured by Neutron Flight II inventory reserves, so headline growth may not translate into sustainable near-term profitability.
Background
This is a Q2 2026 earnings call summary describing Rocket Lab’s strategic pivot toward end-to-end space applications, Iridium acquisition plans, and Neutron development and cadence.
Ticker impact
Rocket Lab said Q2 revenue rose 62% YoY, with Space Systems at 60% of $2.36B backlog, plus Iridium acquisition and Neutron cadence guidance.
Bias toward upside on backlog and ASP discipline, but expect volatility around Neutron inventory spending, margin normalization timing, and Iridium close timing.
The article provides multiple concrete management disclosures: backlog mix, ASP range ($50M to $55M), Neutron delivery timing (Q4 2026), spending shift into flight hardware inventory, and a mid-2027 FCF reset narrative. These are actionable for positioning, though the piece is a call summary rather than a fresh filing or print.
Market effects
Reinforces demand tightness in launch capacity through 2029 and supports the broader narrative of vertically integrated space services moving from launch to recurring applications.
Europe expansion via Mynaric and Rocket Lab Germany targets regional launch and manufacturing gaps, potentially affecting competitive dynamics for European space primes.
Iridium L-band spectrum framing highlights continued strategic value of spectrum assets for PNT, IoT, and direct-to-device services.
Counterpoint
The margin and cash flow outlook relies on future Neutron test success and Iridium closing, so near-term valuation may be vulnerable to execution risk and timing slippage.
Key entities
- companyRocket Lab USA, Inc.
Discussed Q2 results, Neutron scaling plan, Iridium acquisition rationale, and guidance on margins, cash burn, and cadence.
- companyIridium
Pending acquisition described as enabling a self-launching, recurring space applications strategy via L-band spectrum.
- companyMynaric
Acquisition used to expand into Europe and support payload integration for GEO satellite contracts.
- programNeutron
Rocket development program with a target launch pad delivery in Q4 2026 and a planned cadence ramp.
- platformFlatellite
Space Force program platform debut cited as validation for high-cadence constellation deployment.
